BioSpace News Archive

Career Advice

How to Master Interview Small Talk

How do you leave your nerves behind and show your interviewer the real you? Here are a few tips for mastering interview small talk.

October 29, 2019
·
3 min read
·
Laura Brothers
Drug Development

Mirati’s KRAS Inhibitor Promising in Early-Stage Trial of Solid Tumors

San Diego-based Mirati Therapeutics announced the first clinical data from its Phase I/II clinical trial of MRTX849 in solid tumors. MRTX849 is a KRAS G12C inhibitor.

October 29, 2019
·
2 min read
·
Mark Terry
Policy

PixarBio CEO Who Claimed He Cured Paralysis Convicted of Defrauding Investors

Reynolds claimed that his company’s product, called NeuroRelease, could essentially end paralysis.

October 29, 2019
·
2 min read
·
Alex Keown
Drug Development

Top 10 Clinical Trial Indications in the Bay Area

BioSpace has put together a list of the top 10 indications that have been or are the subject of being researched across the region by pharma companies, academic institutions and other organizations. The trials range from Phase I to Phase III.

October 29, 2019
·
3 min read
·
Alex Keown
Career Advice

Word Choice Can Make a Big Difference in Resumes and Cover Letters

The words and phrases you choose in your resume and cover letter can have a surprisingly powerful impact.

October 29, 2019
·
5 min read
·
Katharine Hansen, PhD
Deals

Lonza to Host New Webinar – “Paper to EBR in 9 Months: How a Strong Collaboration Leads to Project Success”

Free Lonza webinar to discuss the benefits of a collaborative approach to implementing an Electronic Batch Record Platform

October 29, 2019
·
3 min read
Pharm Country

WCG Clinical Research Thought Leaders to Present at MAGI West

Topics to be covered include IRB outsourcing, human subject protections and data privacy, patient-centric clinical trials, and the evolving clinical site landscape

October 29, 2019
·
2 min read
BioCapital

TRICARE extends temporary prescription changes for beneficiaries throughout California until Nov. 6

The Defense Health Agency announced TRICARE beneficiaries throughout the State of California may receive emergency prescription refills until Nov. 6 if they need them, as a result of the current wildfires.

October 29, 2019
·
1 min read
APX3330 Phase I Oncology Trial Presented at AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Meeting

Apexian Pharmaceuticals, Inc., a clinical-stage drug development company focused on advancing APX3330 for the treatment of diseases mediated by the APE1/Ref-1 protein, presented additional data on their Phase 1 study using APX3330 in patients with advanced solid tumors.

October 29, 2019
·
1 min read
Deals

Sense Biodetection Raises £12.3m to Progress Instrument-Free Molecular Diagnostics

Initial focus on diagnosing infectious disease through development of machine-free, lab-quality, True Point-of-Care™ products

October 29, 2019
·
4 min read